Vanguard Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $194M | Buy |
|
|||||
|
2025
Q2 | $183M | Buy |
|
|||||
|
2025
Q1 | $171M | Sell |
|
|||||
|
2024
Q4 | $230M | Buy |
|
|||||
|
2024
Q3 | $160M | Buy |
|
|||||
|
2024
Q2 | $162M | Buy |
|
|||||
|
2024
Q1 | $160M | Buy |
|
|||||
|
2023
Q4 | $154M | Buy |
|
|||||
|
2023
Q3 | $119M | Buy |
|
|||||
|
2023
Q2 | $84.1M | Buy |
|
|||||
|
2023
Q1 | $72.9M | Buy |
|
|||||
|
2022
Q4 | $77.5M | Buy |
|
|||||
|
2022
Q3 | $89.2M | Buy |
|
|||||
|
2022
Q2 | $56.9M | Buy |
|
|||||
|
2022
Q1 | $47.3M | Buy |
|
|||||
|
2021
Q4 | $105M | Buy |
|
|||||
|
2021
Q3 | $62.4M | Buy |
|
|||||
|
2021
Q2 | $97.9M | Buy |
|